Mobile Apps for the Care Management of Chronic Kidney and End-Stage Renal Diseases: Systematic Search in App Stores and Evaluation.
Mobile App Rating Scale
digital health
kidney patient
mhealth
mobile apps
nutrition tracking
systematic assessment
Journal
JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439
Informations de publication
Date de publication:
04 09 2019
04 09 2019
Historique:
received:
25
10
2018
accepted:
19
06
2019
revised:
05
03
2019
entrez:
6
9
2019
pubmed:
6
9
2019
medline:
1
9
2020
Statut:
epublish
Résumé
Numerous free and low-cost mobile apps for the care management of kidney disease have become available in recent years. Although these appear to be promising tools, they have not been evaluated comparatively based on standard mobile app metrics, and thus, limited evidence is available regarding their efficacy. This study systematically cataloged and assessed mobile apps designed to assist medication compliance and nutrition tracking that are useful to the chronic kidney disease (CKD) and the end-stage renal disease (ESRD) patients who are on dialysis. The objective of this study was to comprehensively evaluate mobile apps used for medication compliance and nutrition tracking for possible use by CKD and ESRD patients. A systematic review framework was applied to the search, screening, and assessment of apps identified and downloaded from the iOS and Android app stores. We selected apps using 13 relevant search terms, narrowed down based on a set of inclusion and exclusion criteria, and then used the Mobile App Rating Scale (MARS), a widely adopted app evaluation tool to assess the effectiveness of apps. The internal consistency and interrater reliability were tested using Cronbach alpha and interclass correlation coefficients (ICCs), respectively. The MARS total score had excellent internal consistency (Cronbach alpha=.90) and a moderate level of interrater reliability (2-way mixed ICC 0.65). Overall, 11 out of the 12 reviewed apps met the minimum acceptable score of 3.0 in MARS rating. The 3 apps with the highest combined scores were My Kidneys, My Health Handbook (MARS=4.68); My Food Coach (MARS=4.48); and National Kidney Foundation Malaysia (MARS=4.20). The study identified 2 general weaknesses in the existing apps: the apps fell short of accommodating advanced interactive features such as providing motivational feedback and promoting family member and caregiver participations in the app utilization. The MARS rating system performed well in the app evaluation. The 3 highest ranked apps scored consistently high across the 5 dimensions specified in MARS. These apps were developed in collaboration with reputable organizations and field experts, demonstrating the importance of expert guidance in developing medical apps.
Sections du résumé
BACKGROUND
Numerous free and low-cost mobile apps for the care management of kidney disease have become available in recent years. Although these appear to be promising tools, they have not been evaluated comparatively based on standard mobile app metrics, and thus, limited evidence is available regarding their efficacy. This study systematically cataloged and assessed mobile apps designed to assist medication compliance and nutrition tracking that are useful to the chronic kidney disease (CKD) and the end-stage renal disease (ESRD) patients who are on dialysis.
OBJECTIVE
The objective of this study was to comprehensively evaluate mobile apps used for medication compliance and nutrition tracking for possible use by CKD and ESRD patients.
METHODS
A systematic review framework was applied to the search, screening, and assessment of apps identified and downloaded from the iOS and Android app stores. We selected apps using 13 relevant search terms, narrowed down based on a set of inclusion and exclusion criteria, and then used the Mobile App Rating Scale (MARS), a widely adopted app evaluation tool to assess the effectiveness of apps. The internal consistency and interrater reliability were tested using Cronbach alpha and interclass correlation coefficients (ICCs), respectively.
RESULTS
The MARS total score had excellent internal consistency (Cronbach alpha=.90) and a moderate level of interrater reliability (2-way mixed ICC 0.65). Overall, 11 out of the 12 reviewed apps met the minimum acceptable score of 3.0 in MARS rating. The 3 apps with the highest combined scores were My Kidneys, My Health Handbook (MARS=4.68); My Food Coach (MARS=4.48); and National Kidney Foundation Malaysia (MARS=4.20). The study identified 2 general weaknesses in the existing apps: the apps fell short of accommodating advanced interactive features such as providing motivational feedback and promoting family member and caregiver participations in the app utilization.
CONCLUSIONS
The MARS rating system performed well in the app evaluation. The 3 highest ranked apps scored consistently high across the 5 dimensions specified in MARS. These apps were developed in collaboration with reputable organizations and field experts, demonstrating the importance of expert guidance in developing medical apps.
Identifiants
pubmed: 31486408
pii: v7i9e12604
doi: 10.2196/12604
pmc: PMC6753688
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12604Informations de copyright
©Abu Bakkar Siddique, Mary Krebs, Sarai Alvarez, Iris Greenspan, Amit Patel, Julianna Kinsolving, Naoru Koizumi. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 04.09.2019.
Références
J Am Med Inform Assoc. 2014 May-Jun;21(3):542-6
pubmed: 24163156
Children (Basel). 2018 Jan 26;5(2):null
pubmed: 29373515
PLoS One. 2016 Apr 13;11(4):e0152285
pubmed: 27073900
Transpl Int. 2013 Dec;26(12):1161-3
pubmed: 24118445
BMC Med. 2015 Mar 23;13:58
pubmed: 25857569
JMIR Mhealth Uhealth. 2018 Mar 28;6(3):e74
pubmed: 29592848
Clin J Am Soc Nephrol. 2009 May;4(5):950-6
pubmed: 19389825
Int J Behav Nutr Phys Act. 2016 Mar 10;13:35
pubmed: 26964880
Appl Ergon. 2010 May;41(3):403-10
pubmed: 19892317
BMC Nephrol. 2014 Jan 09;15:7
pubmed: 24405907
J Med Internet Res. 2015 Aug 17;17(8):e198
pubmed: 26283290
Diabetes Technol Ther. 2016 Mar;18(3):200-12
pubmed: 26950679
JAMA. 2015 Apr 14;313(14):1405-7
pubmed: 25871657
JMIR Mhealth Uhealth. 2015 Aug 19;3(3):e82
pubmed: 26290327
Stat Med. 2012 Dec 20;31(29):3972-81
pubmed: 22764084
J Med Internet Res. 2014 Apr 09;16(4):e104
pubmed: 24718852
JMIR Mhealth Uhealth. 2016 Jun 14;4(2):e74
pubmed: 27302310
Nephrol Nurs J. 2004 Jul-Aug;31(4):378-86, 396; quiz 387
pubmed: 15453230
Kidney Int. 2011 Dec;80(12):1344-51
pubmed: 21832984
Epilepsy Behav. 2018 Apr;81:62-69
pubmed: 29494935
JMIR Mhealth Uhealth. 2015 Mar 11;3(1):e27
pubmed: 25760773
Am J Kidney Dis. 2011 Apr;57(4):583-91
pubmed: 21131116
JMIR Ment Health. 2014 Dec 23;1(1):e5
pubmed: 26543905
JMIR Mhealth Uhealth. 2016 Feb 10;4(1):e15
pubmed: 26863986